Latest News From BioPharmaChem

    December 2016

  • Case Study: How Clinical Trial Helped One Cancer Patient

    01 December, 2016

    Participants in clinical trials may feel as though they are being used as guinea pigs. In some cases such as the one discussed in the article below, there is a lot that a patient can gain from a clinical trial. A man called Frank O' Duffy from Nenagh, Co. Tipperary took part in a phase III clinical trial. This is where the drug is administered to a patient who is suffering from the condition that the drug is trying to treat. At this stage, Frank's cancer had moved from a melanoma on his shin to his liver and his lungs. After taking part in a clinical trial his liver is now almost cancer-free. These trials allow patients to access new experimental drugs which may save their lives.

    Continue Reading »

  • West Pharmaceuticals to Create 100 New Jobs in Dublin Expansion

    02 December, 2016

    West pharma plans to expand its Dublin-based facility over the next 5 years. This will open 100 positions in the company. West pharma is a contract manufacturer of pharmaceutical components. They produce injection needles, caps and glassware for the containment and administration of pharmaceutical products. This is followed by the construction of a West pharma facility in Waterford city.

    Continue Reading »

  • Japanese Pharma Group to Invest €40m in New Dublin Facility

    05 December, 2016

    Takeda Pharmaceuticals plans to open a new facility in Dublin. The company will invest €40m to build this factory. Takeda has established three other facilities in Ireland. The other facilities are based in Grange Castle, City West and Bray. The site in Grange Castle is the world centre for the manufacture and development of Active pharmaceutical ingredients for Takeda. The companies investment into this new facility shows the Japanese companies continued interest in Ireland as an integral part of their global network.

    Continue Reading »

  • Osteoporosis Test Developed at UL to Benefit Millions of People

    08 December, 2016

    Ostentia, a technology which was in development in University Limerick between 2004 and now, will allow patients to diagnose whether they have osteoporosis from home. Before this technology was developed patients would need to undergo a bone mineral density test (BMD). The BMD test is similar to an X-Ray so this would require the patient to attend the hospital to be tested. The newly developed Ostentia however, can analyse a nail cutting and determine whether the patient has osteoporosis. The nail clipping is then put into a package and sent to the laboratory for testing. This is great for patients, they do not need to go to a hospital and a diagnosis can be given within 7 days. It is a fantastic innovation developed in Ireland.

    Continue Reading »

  • There's Much More to Ireland than Tax Breaks - Pharma Boss Grainne McAleese

    13 December, 2016

    Alexion, a company that produces drug products such as Soliris which help to treat ultra-rare diseases. These diseases can be life threatening for the patients that live with them because there is not extensive research done on these diseases. They are termed as orphan drugs and there are government intensives in place to give these companies the capital to conduct the research and to manufacture these drugs.This helps the patients to get a better quality of life and allows them to live longer. The article is an interview with Grainne McAleese, the general manager of the Alexion, Blanchardstown. Ms McAleese outlined Ireland's attractiveness to global pharmaceutical companies. We have the training, the infrastructure and the research centres which make us such an attractive location to establish a site. Ireland is a boiling pot with all of the right ingredients to allow the pharmaceutical industry to flourish, here.

    Continue Reading »

  • Amgen’s Adrian Bennis: Ireland at the cutting edge of fighting cancer

    15 December, 2016

    Traditional cancer drugs normally kill all kinds of cells. They do not distinguish between healthy and cancerous cells. This is quite a problem when fighting cancer with these more traditional drugs such as cisplatin or interferon. Side effects such as hair loss and nausea are caused by the cancer medication killing these quickly dividing cells. If more selective treatments are developed then cancer patients will not have to go through this ordeal. Amgen in Dún Laoghaire is developing a new cancer-fighting technology. This new technology is called BiTE ( see the video for more information). BiTE technology allows the body's immune system to better target cancer cells. It uses an antibody to bridge between t-cells, the cells that break down cancer cells, and the cancer cells so that your immune system can better fight off cancer. This will provide a better treatment for patients which has less severe side effects.

    Continue Reading »

  • Boom Time for Pharma Industry

    20 December, 2016

    The pharmaceutical sector in Ireland is still booming. The boom has been caused by a number of factors including clever government investment, industry/academic collaboration and an educated workforce. All of these factors make Ireland an attractive place for foreign investment. If anybody is in any way wondering whether the pharmaceutical sector is for them you should have a look at this article. It should convince you that it is a sector of growth with a good potential for career progression.

    Continue Reading »